Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Assets: 2020-2025

Historic Assets for P3 Health Partners (PIII) over the last 6 years, with Q3 2025 value amounting to $683.6 million.

  • P3 Health Partners' Assets fell 1797.23% to $683.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year decrease of 1337.63%. This contributed to the annual value of $783.4 million for FY2024, which is 900.7% down from last year.
  • According to the latest figures from Q3 2025, P3 Health Partners' Assets is $683.6 million, which was down 1797.23% from $731.6 million recorded in Q2 2025.
  • In the past 5 years, P3 Health Partners' Assets ranged from a high of $2.4 billion in Q1 2022 and a low of $100.7 million during Q1 2021
  • Over the past 5 years, P3 Health Partners' median Assets value was $858.4 million (recorded in 2023), while the average stood at $883.0 million.
  • In the last 5 years, P3 Health Partners' Assets skyrocketed by 223973.22% in 2022 and then tumbled by 6319.24% in 2023.
  • Quarter analysis of 5 years shows P3 Health Partners' Assets stood at $316.6 million in 2021, then soared by 176.85% to $876.6 million in 2022, then fell by 1.78% to $861.0 million in 2023, then dropped by 9.01% to $783.4 million in 2024, then fell by 12.75% to $683.6 million in 2025.
  • Its last three reported values are $683.6 million in Q3 2025, $731.6 million for Q2 2025, and $783.9 million during Q1 2025.